亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢遠城科技發展有限公司銷售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經營的生物化工、醫藥中間體等產品

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:劉
  • 電話:02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 氯諾昔康
氯諾昔康
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2011-04-16 11:43
 
詳細信息
氯諾昔康 
英文名稱: Lornoxicam 
CAS: 70374-39-9 
化學名稱: 6-氯-4-羥基-2-甲基-N-2-吡啶基-2H-噻吩-〔2,3-e〕
-1,2-噻嗪-3-碳乙二酰乙二胺-1,1-二氧化物 
分子式: C13H10ClN3O4S2 
分子量:371.5
外觀:黃色結晶性粉末
含量:≥99%
用途: 本品可用于婦產科、口腔拔牙、矯形手術及外科術后急性疼痛、
外傷引起的中~重度疼痛、急性坐骨神經痛和腰痛、晚期癌痛,亦可用于慢性腰
痛、骨關節炎、類風濕關節炎和強直性脊椎炎的治療。新型解熱鎮痛類藥物 
包裝規格: 5kg/聽 
Lornoxicam
CAS: 70374-39-9
Chemical Name: 6 - chloro -4-- hydroxy -2-- methyl-N-2-pyridyl-2H-thiophene -〕
 〔2,3-e 1,2 - thiazine -3-- carbon acid ethylene glycol amine 1,1 - dioxide
Molecular formula: C13H10ClN3O4S2
Molecular weight: 371.5
Appearance: yellow crystalline powder
Content: ≥ 99%
Packing: 5kg / Listen 
Uses: It can be used in obstetrics and gynecology, dental
 extractions, orthopedic surgery and acute pain after surgery, 
trauma caused by moderate to severe pain, acute sciatica and 
back pain, advanced cancer, can be used for chronic lumbar
Pain, osteoarthritis, rheumatoid arthritis and ankylosing
 spondylitis treatment. New anti-inflammatory drugs


©2025 武漢遠城科技發展有限公司銷售八部 版權所有   技術支持:化工網   訪問量:27692  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |